The Troponin I assay expands the cardiological risk-profile
As of today, Eurolyser Diagnostica offers a Troponin I Assay for the Eurolyser smart Point of Care Instrument range.
Since cardiovascular diseases are still the number one in cause of death statistics, diagnosis and therapy of these diseases continuously seeks to improve. The Troponin I Assay has already become a standard test that shows damages to the heart muscle tissue. Reports show that determining Troponin I enables early defect detection and stratification of patients suffering from chest pain of ischemic origin.
The new Eurolyser smart Troponin I Assay – along with the existing Point of care tests Homocysteine, Lipoprotein (a) and hsCRP (high sensitive CRP) – facilitates the immediate diagnosis of a patient’s cardiological status during a visit in the doctor’s practice.
The Cardio Troponin I test is based on a latex enhanced immuneturbidimetric assay. When mixed with a sample, Cardio Troponin I binds with the specific latex-coated anti troponin I antibodies and causes agglutination. The degree of turbidity due to agglutination can be measured optically and is proportional to the amount of Troponin I in the sample.
Linear to: 10,00 ng/ml
Limit of detection: 0,30 ng/ml
The cardio-troponin I Assay was determined in a reference range study according to the CLSI C28-A3 protocol conducted with serum of healthy adults aging from 16 to 71. The recommended measurement range is 0.00 – 1.50 ng/ml. This range, however, is for orientation purposes only. Every laboratory should compile its own reference values.
Kit size: 6 tests per kit
Article number: ST 0230